Journal article
Management of inflammatory bowel disease
Emily K Wright, Nik S Ding, Ola Niewiadomski
The Medical Journal of Australia | AUSTRALASIAN MED PUBL CO LTD | Published : 2018
DOI: 10.5694/mja17.01001
Abstract
Australia has one of the highest incidence rates of inflammatory bowel disease (IBD) in the world. Early diagnosis and treatment for IBD is critical. For Crohn disease, in particular, this may change the natural history of disease and reduce disability. Faecal calprotectin is a sensitive test that can be used by primary care physicians to assist in determining which patients with gastrointestinal symptoms may have IBD. This allows for prompt identification of patients who may benefit from endoscopy. Regular re-evaluation of disease status with strategies that can safely, readily and reliably detect the presence of inflammation with faecal biomarkers and imaging is important. To avoid the ris..
View full abstract